
Opinion|Videos|February 25, 2025
Role of Patient History in Neurogenic Bladder Diagnosis
Author(s)Tamara Kaplan, MD
Panelist discusses how a detailed patient history is critical for neurological lesion localization, helping physicians map symptoms to specific anatomical regions. Key bladder-related history focuses on urinary urgency, frequency, retention, and incontinence patterns, as these symptoms often indicate specific spinal cord or brain lesion locations that affect autonomic function.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What role does a detailed patient history play in localizing neurological lesions?
- What are the key questions neurologists should ask when taking a patient’s history about bladder symptoms?
Advertisement
Related to this article

Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of neurology!

Although ocular signs in LEMS are typically mild and appear late, recognizing them alongside proximal weakness and autonomic symptoms can speed diagnosis and earlier detection of an associated lung cancer.

Shaida Khan, DO, associate professor of neurology at UT Southwestern Medical Center, reflected on a recent NeurologyLive Clinical Forum on generalized myasthenia gravis and discussed how FcRn and complement inhibitors are reshaping treatment algorithms for the disease.

The phase 3 TRONTIER 1 and 2 trials will test whether trontinemab's faster brain entry and rapid amyloid clearance translate into slower clinical decline in early Alzheimer disease.

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with M. Scott Perry, MD. [LISTEN TIME: 15 minutes]
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Examining Trontinemab in Early Alzheimer Disease: The Phase 3 TRONTIER 1 and 2 Trials
2
Benitec Reports Positive Interim Results for BB-301 in Oculopharyngeal Muscular Dsytrophy
3
How MS Understanding Has Evolved: Activity, Impact, and Progression
4
Remibrutinib Phase 3 Results in RMS, Blood Pressure Variability Findings, and Updated Stroke Rehabilitation Guidelines
5



